Osteoporosis is a systemic disease that affects the entire skeletal system. It is manifested by a reduction in bone mass and the deterioration of the structure, leading to increased bone fragility and an increased risk of fractures. The areas most prone to fractures are the hip, spine, wrists and shoulders. There are four types of osteoporosis named after the age of onset of the disease: Juvenile, Idiopathic, Post-menopausal (Type I) and Senile (Type II).
In its most common form several factors influence the onset of the disease and can be divided into modifiable and non-modifiable factors. Modifiable factors include elements associated to lifestyle (smoking, alcohol, coffee, and a sedentary lifestyle), diet (low calcium intake, excessive intake of protein and phosphorus), use of medications and concomitant conditions such as anorexia and hypogonadism. The non-modifiable factors indicate an increased incidence of osteoporosis in females, people with Asian and Caucasian ethnicity, in people of an advanced age, a thin body structure and people prone to the disease.
TMR® therapy acts by increasing the expression of osteogenic genes and therefore the presence of osteblasts, the cells responsible for formation of new bone tissue. The peculiarity of the pulsed magnetic field is in fact the ability to stimulate bone tissue both mechanically and electrically, promoting osteo-repair.
Moreover, TMR® treatment is able to reduce pain perception, often present in patients with this condition.